Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Duan, Hongxia ^a   Xing, Shu ^a   Luo, Yongting ^a   Feng, Liqun ^b   Gramaglia, Irene ^c   Zhang, Ying ^a   Lu, Di ^a   Zeng, Qiqun ^a   Fan, Kelong ^a   Feng, Jing ^a   Yang, Dongling ^a   Qin, Zhihai ^a   Couraud, Pierre Olivier ^d   Romero, Ignacio A ^e   Weksler, Babette ^f   Yan, Xiyun ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c La Jolla Infectious Disease Institute   (United States)

^d INSTITUT COCHIN   (France)

^e OPEN UNIVERSITY   (United Kingdom)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; MCAM PROTEIN, MOUSE;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; ENCEPHALITIS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD146; BRAIN; ENCEPHALITIS; ENDOTHELIUM, VASCULAR; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS;

EID: 84885672794     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01687     Document Type: Article

References (57)

1. Frohman, E. M., Racke, M. K. & Raine, C. S. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 354, 942-955 (2006).
2. Centonze, D. et al. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 17, 1083-1091 (2010).
3. Engelhardt, B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 113, 477-485 (2006).
4. Waubant, E. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers 22, 235-244 (2006).
5. Von Andrian, U. H. & Mackay, C. R. T-cell function and migration. Two sides of the same coin. N Engl J Med 343, 1020-1034 (2000).
6. Carrithers, M. D., Visintin, I., Kang, S. J. & Janeway, C. A., Jr. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123(Pt6), 1092-1101 (2000).
7. Carman, C. V. & Springer, T. A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 167, 377-388 (2004).
8. Schenkel, A. R., Mamdouh, Z. & Muller, W. A. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 5, 393-400 (2004).
9. Van Kempen, L. C. et al. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276, 25783-25790 (2001).
10. Pollerberg, G. E., Thelen, K., Theiss, M. O. & Hochlehnert, B. C. The role of cell adhesion molecules for navigating axons: Density matters. Mech Dev (2012).
11. Cayrol, R. et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 9, 137-145 (2008).
12. Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356, 63-66 (1992).
13. Von Andrian, U. H. & Engelhardt, B. Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 348, 68-72 (2003).
14. Ransohoff, R. M. Natalizumab for multiple sclerosis. N Engl J Med 356, 2622-2629 (2007).
15. Wood, H. Multiple sclerosis: Benefits of alemtuzumab in MS. Nat Rev Neurol 7, 245 (2011).
16. Nguyen, K., Sylvain, N. R. & Bunnell, S. C. T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76. Immunity 28, 810-821 (2008).
17. Lopez-Diego, R. S. & Weiner, H. L. Novel therapeutic strategies for multiple sclerosis-a multifaceted adversary. Nat Rev Drug Discov 7, 909-925 (2008).
18. Polman, C. H. & Uitdehaag, B. M. New and emerging treatment options for multiple sclerosis. Lancet Neurol 2, 563-566 (2003).
19. Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A. & George, A. J. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov 9, 325-338 (2010).
20. Luo, Y. et al. Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration. Oncogene 31, 306-321 (2012).
21. Zeng, Q. et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 109, 1127-1132 (2012).
22. Yan, X. et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102, 184-191 (2003).
23. Jiang, T. et al. CD146 is a co-receptor for VEGFR-2 in tumor angiogenesis. Blood (2012).
24. Neidhart, M. et al. Synovial fluid CD146(MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum 42, 622-630 (1999).
25. Tsiolakidou, G., Koutroubakis, I. E., Tzardi, M. & Kouroumalis, E. A. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 40, 673-679 (2008).
26. Zhang, B. R. et al. Elevated Levels of Soluble and Neutrophil CD146 in Active Systemic Vasculitis. Labmedicine 40, 351-356 (2009).
27. Larochelle, C. et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 135, 2906-2924 (2012).
28. Kebir, H. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13, 1173-1175 (2007).
29. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and TH17 Cells. Annu Rev Immunol 27, 485-517 (2009).
30. El-behi, M., Rostami, A. & Ciric, B. Current views on the roles of TH1 and TH17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 5, 189-197 (2010).
31. Rothhammer, V. et al. TH17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J Exp Med 208, 2465-2476 (2011).
32. Stromnes, I. M. & Goverman, J. M. Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1, 1952-1960 (2006).
33. Weksler, B. B. et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19, 1872-1874 (2005).
34. Caminero, A., Comabella, M. & Montalban, X. Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story. J Neuroimmunol 234, 1-6 (2011).
35. May, M. J. & Ager, A. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta. Eur J Immunol 22, 219-226 (1992).
36. Wong, D., Prameya, R. & Dorovini-Zis, K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J Neuropathol Exp Neurol 58, 138-152 (1999).
37. Flanagan, K. et al. Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. PLoS One 7, e40443 (2012).
38. Arima, Y. et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148, 447-457 (2012).
39. Yura, M. et al. Role of MOG-stimulated TH1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). J Autoimmun 17, 17-25 (2001).
40. Jadidi-Niaragh, F. & Mirshafiey, A. TH17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74, 1-13 (2011).
41. Ransohoff, R. M. & Engelhardt, B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12, 623-635 (2012).
42. Engelhardt, B. & Ransohoff, R. M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26, 485-495 (2005).
43. Berger, J. R. & Koralnik, I. J. Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N Engl J Med 353, 414-416 (2005).
44. Elshal, M. F., Khan, S. S., Takahashi, Y., Solomon, M. A. & McCoy, J. P., Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 106, 2923-2924 (2005).
45. Pickl, W. F. et al. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 158, 2107-2115 (1997).
46. Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J. & Tolosa, E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329-3341 (2009).
47. Dagur, P. K. et al. CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry B Clin Cytom 78, 88-95 (2010).
48. Guezguez, B. et al. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 inlymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol 179, 6673-6685 (2007).
49. Elshal, M. F. et al. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol 8, 29 (2007).
50. Venneri, M. A. et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109, 5276-5285 (2007).
51. Murdoch, C., Tazzyman, S., Webster, S. & Lewis, C. E. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178, 7405-7411 (2007).
52. Zhang, Y. et al. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146. Hybridoma (Larchmt) 27, 345-352 (2008).
53. Stromnes, I. M. & Goverman, J. M. Active induction of experimental allergic encephalomyelitis. Nat Protoc 1, 1810-1819 (2006).
54. Zheng, C. et al. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J Biochem Cell Biol 41, 2163-2172 (2009).
55. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8, 950-957 (2007).
56. Bi, Y. & Yang, R. Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions. Scand J Immunol 75, 543-552 (2012).
57. Mestre, L. et al. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB (1) receptors. J Neuroinflammation 8, 102 (2011).